These studies confirm the clinical potential of DP synthetic lung surfactant with B-YL peptide as a SP-B mimic to alleviate surfactant deficiency when delivered as a liquid bolus or as an aerosol. Here, SFTPB is linked to hyperinsulinemic hypoglycemia, familial, 4.